Literature DB >> 17945176

Synthesis of sulfonamide- and sulfonyl-phenylboronic acid-modified silica phases for boronate affinity chromatography at physiological pH.

Xiaobao Li1, Justin Pennington, John F Stobaugh, Christian Schöneich.   

Abstract

Two new types of boronate affinity solid phases were synthesized and characterized. The materials were prepared by silylation of porous silica gel with monochlorosilane derivatives containing synthetic sulfonyl- and sulfonamide-substituted phenylboronic acids. The new solid phases were evaluated for boronate affinity chromatography with aryl and alkyl cis-diol compounds and were found to be suitable for the retention of cis-diols under acidic conditions. Significant correlations between the retention factor (K) and the pH of the mobile phase demonstrate that the binding of cis-diols to the solid phases is best rationalized by chelation. Based on the lower pKa, caused by the electron-withdrawing effects of the sulfonyl and sulfonamide groups, these media display an enhanced affinity for cis-diols as compared with unsubstituted phenylboronic acid. Using isocratic elution, a mixture of various biologically relevant l-tyrosines, l-DOPA, and several catecholamines were resolved with a mobile phase composed of 0.05M phosphate buffer (pH 5.5). Mono-, di-, and triphosphates of adenosine were also separated at pH 6.0. Hence, the new boronate solid phase offers efficient affinity separation and purification of cis-diol-containing molecules under rather mild pH conditions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17945176      PMCID: PMC2212591          DOI: 10.1016/j.ab.2007.09.001

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  12 in total

Review 1.  Clinical applications of high-performance affinity chromatography.

Authors:  David S Hage
Journal:  Adv Chromatogr       Date:  2003

2.  Reactivity of peptidyl-tyrosine to hydroxylation and cross-linking.

Authors:  L A Burzio; J H Waite
Journal:  Protein Sci       Date:  2001-04       Impact factor: 6.725

Review 3.  Current chemical tagging strategies for proteome analysis by mass spectrometry.

Authors:  Alexander Leitner; Wolfgang Lindner
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2004-12-25       Impact factor: 3.205

Review 4.  Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin.

Authors:  L Bry; P C Chen; D B Sacks
Journal:  Clin Chem       Date:  2001-02       Impact factor: 8.327

5.  Markers of protein oxidation by hydroxyl radical and reactive nitrogen species in tissues of aging rats.

Authors:  C Leeuwenburgh; P Hansen; A Shaish; J O Holloszy; J W Heinecke
Journal:  Am J Physiol       Date:  1998-02

6.  Optimization of hydroxylation of tyrosine and tyrosine-containing peptides by mushroom tyrosinase.

Authors:  K Marumo; J H Waite
Journal:  Biochim Biophys Acta       Date:  1986-07-25

7.  Alkylation of 2'-deoxynucleosides and DNA by the Premarin metabolite 4-hydroxyequilenin semiquinone radical.

Authors:  L Shen; S Qiu; Y Chen; F Zhang; R B van Breemen; D Nikolic; J L Bolton
Journal:  Chem Res Toxicol       Date:  1998-02       Impact factor: 3.739

8.  Insulins with built-in glucose sensors for glucose responsive insulin release.

Authors:  Thomas Hoeg-Jensen; Signe Ridderberg; Svend Havelund; Lauge Schäffer; Per Balschmidt; Ib Jonassen; Per Vedsø; Preben H Olesen; Jan Markussen
Journal:  J Pept Sci       Date:  2005-06       Impact factor: 1.905

Review 9.  Post-translational non-enzymatic modification of proteins. II. Separation of selected protein species after glycation and other carbonyl-mediated modifications.

Authors:  I Miksík; Z Deyl
Journal:  J Chromatogr B Biomed Sci Appl       Date:  1997-10-10

Review 10.  Protein glycation: measurement and clinical relevance.

Authors:  E Schleicher; O H Wieland
Journal:  J Clin Chem Clin Biochem       Date:  1989-09
View more
  7 in total

1.  Amorphous titania modified with boric acid for selective capture of glycoproteins.

Authors:  Shanxia Jin; Liping Liu; Ping Zhou
Journal:  Mikrochim Acta       Date:  2018-05-22       Impact factor: 5.833

2.  A methodology for simultaneous fluorogenic derivatization and boronate affinity enrichment of 3-nitrotyrosine-containing peptides.

Authors:  Elena S Dremina; Xiaobao Li; Nadezhda A Galeva; Victor S Sharov; John F Stobaugh; Christian Schöneich
Journal:  Anal Biochem       Date:  2011-07-28       Impact factor: 3.365

3.  An Optimised Di-Boronate-ChemMatrix Affinity Chromatography to Trap Deoxyfructosylated Peptides as Biomarkers of Glycation.

Authors:  Monika Kijewska; Francesca Nuti; Magdalena Wierzbicka; Mateusz Waliczek; Patrycja Ledwoń; Agnieszka Staśkiewicz; Feliciana Real-Fernandez; Giuseppina Sabatino; Paolo Rovero; Piotr Stefanowicz; Zbigniew Szewczuk; Anna Maria Papini
Journal:  Molecules       Date:  2020-02-10       Impact factor: 4.411

Review 4.  Microneedle-based insulin transdermal delivery system: current status and translation challenges.

Authors:  Jing Zhao; Genying Xu; Xin Yao; Huirui Zhou; Boyang Lyu; Shuangshuang Pei; Ping Wen
Journal:  Drug Deliv Transl Res       Date:  2021-10-20       Impact factor: 5.671

5.  Branched polyethyleneimine-assisted 3-carboxybenzoboroxole improved Wulff-type boronic acid functionalized magnetic nanoparticles for the specific capture of cis-diol-containing flavonoids under neutral conditions.

Authors:  Daojin Li; Zheyao Liu; Rumeng Song; Wenliu Yang; Simeng Zhai; Wenhui Wang
Journal:  RSC Adv       Date:  2019-11-21       Impact factor: 4.036

6.  Nanoparticles prepared from pterostilbene reduce blood glucose and improve diabetes complications.

Authors:  Xi Zhao; Anhua Shi; Qiong Ma; Xueyan Yan; Ligong Bian; Pengyue Zhang; Junzi Wu
Journal:  J Nanobiotechnology       Date:  2021-06-27       Impact factor: 10.435

Review 7.  Boronic Acid-based approach for separation and immobilization of glycoproteins and its application in sensing.

Authors:  Xiaojin Wang; Ning Xia; Lin Liu
Journal:  Int J Mol Sci       Date:  2013-10-17       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.